The Royal Marsden opened its doors in 1851 as one of the world’s first hospitals dedicated to cancer diagnosis, treatment, research and education.
Today, together with its academic partner, The Institute of Cancer Research (ICR), it is one of the largest cancer centres in Europe, seeing and treating over 60,000 NHS and private patients every year. It is a centre of excellence with an international reputation for ground-breaking research and pioneering the very latest in cancer treatments and technologies.
The Royal Marsden, with the ICR, is the only National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Cancer. This supports pioneering research work carried out over a number of different cancer themes.
The Royal Marsden Cancer Charity raises money solely to support The Royal Marsden, a world-leading cancer centre. It ensures Royal Marsden nurses, doctors and research teams can provide the very best care and develop life-saving treatments, which are used across the UK and around the world.
From funding state-of-the-art equipment and ground-breaking research, to creating the very best patient environments, The Royal Marsden Cancer Charity will never stop looking for ways to improve the lives of people affected by cancer.
Dr Richard Lee, Chief Research Information Officer and Senior Lead for involvement of The Royal Marsden NHS Foundation Trust in the UK Health Data Research Alliance (the ‘Alliance’) said:
“We are excited to be working with the Alliance to drive the best digital oncology research in collaboration with other UK centres. By joining, we hope to make new important discoveries with real-world and structured research data that will inform the next generation of tools for early cancer diagnosis and cutting-edge therapies.”